This means that the glucagon pathway can help treat things like high liver fat and poor blood sugar levels
"This can manifest in various ways, with an unpleasant, abnormal or altered taste sensation, and is often described as metallic." A spokesperson for Eli Lilly, maker of Trulicity, Mounjaro and Zepbound, told USA TODAY in an email: "Patient safety is Lillys top priority, and we take any reports regarding patient safety seriously
Gallbladder disease: Cholelithiasis (gallstones) and cholecystitis have been reported with GLP-1 receptor agonist therapies and may also occur with rapid weight loss
If you have diabetes and are taking insulin or sulfonylureas alongside GLP-1 therapy, be alert for hypoglycaemia symptoms and discuss dose adjustments with your healthcare team
If symptoms persist or become more severe, halting the GLP-1 receptor agonist dose titration and assessing the patient for the presence of underlying conditions may be advised